OPTIFAST®Medical Weight Loss Program—Outcomes in the Endocrinology Clinics at UPMC

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 57-LB
Author(s):  
KARLA B. DETOYA ◽  
KATRINA HAN ◽  
BRENNAN R. REGISTER ◽  
DAVID A. ROMETO
2020 ◽  
Author(s):  
Vivienne A Rose ◽  
Elena N Klyushnenkova ◽  
Min Zhang ◽  
Verlyn O Warrington

Abstract Background Diet and lifestyle intervention programs have been shown to be effective in decreasing obesity/overweight and many associated comorbidities in specialty research settings. There is very little information however as to the efficacy of such programs conducted in usual/typical primary care practices. We analysed effectiveness of the Medical Weight Loss Program (MWLP) designed to specifically address overweight/obesity in the setting of an urban academic primary care practice. Objective To determine whether participation in the MWLP within a general primary care setting can result in weight loss. Methods A retrospective medical chart review of patients treated in MWLP and a control group of patients with obesity receiving regular care in the general primary care setting. From the practice database (1 April 2015–31 March 2016), 209 patients (≥18 years old) who participated in the MWLP were identified; 265 controls were selected from the remaining population based on the presence of the obesity-related diagnoses. Results MWLP patients lost on average 2.35 ± 5.88 kg in 6 months compared to their baseline weight (P < 0.0001). In contrast, the control group demonstrated a trend of gaining on average 0.37 ± 6.03 kg. Having three or more visits with the MWLP provider within 6 months after program initiation was the most important factor associated with successful loss of at least 5% of the baseline weight. Weight loss also correlated with a decrease in abdominal girth. Conclusion MWLP integrated into the general primary care practice may potentially be an effective model for managing obesity and related morbidities.


2019 ◽  
Vol 3 (Supplement_1) ◽  
Author(s):  
Vijaya Surampudi ◽  
Katherine Biggs ◽  
Zhaoping Li

Abstract Objectives Very low calorie diets have been utilized for weight loss and glycemic control for several decades. In addition, improvements in blood pressure and cholesterol have been observed but few have reported the change in metabolism of lipoproteins (HDL, LDL and triglycerides (TGs)) during the weight loss process. Several cases have demonstrated the dynamic nature of lipoprotein metabolism during intensive weight loss program. Methods Patients were enrolled in self-paid university based medical weight loss program utilizing a VLCD (500–800 calories) program. In addition, patients were recommended to exercise and participate in group cognitive behavioral counseling. During the program patients CBC, CMP and Lipid panel were monitored. In the following three cases of patients utilizing the VLCD averaging about 800 calories the following changes in lipids were noted. All patients were noted to have improved in triglycerides and HDL. Case #1: 48 y/o male whose baseline weight was 267 lbs with BMI 38 kg/m2 who lost 55 lbs over 5 months and with the lowest weight of 202 lbs and BMI of 29 kg/m2. Over this time LDL baseline was 143 mg/dL improving to 52 mg/dL but later increasing to 178 mg/dL and 6 weeks later normalizing to 72 mg/dL. Case #2: 70 y/o female whose starting weight was 217 lbs with BMI 38 kg/m2 who lost 41 lbs over 5 months and with the lowest weight of 176 and BMI of 31 kg/m2. Over this time LDL baseline was 108 mg/dL but later increasing to 157 mg/dL and 12 weeks later normalizing to 111 mg/dL. Case #3: 55 y/o female whose starting weight was 245 lbs with BMI 39.56 kg/m2 who lost 79 lbs over 8 months and with the lowest weight of 166 lbs and BMI of 26.9 kg/m2. Over this time LDL baseline was 93 mg/dL but later increasing to 136 mg/dL and 12 weeks later normalizing to 108 mg/dL. Results These observations suggest change in the metabolism of lipoproteins, namely by decreasing triglycerides, increasing HDL, and increasing the fraction of large particle-size LDL. A limitation of the LDL measurement is that it is a calculated measurement not taking into account the varying sizes of LDL. More small dense LDL equates to higher risk in coronary artery disease however in the calculated method the size is unclear. Conclusions In these cases we observed a transient increase in LDL however size of LDL measured is unknown. Therefore, any concern about the long-term effects of VLCDs on cardiovascular health will need further prospective studies to help elucidate lipid metabolism as people lose weight. Funding Sources UCLA - Department of Medicine Clinical Nutrition.


2015 ◽  
Vol 11 (2) ◽  
pp. 431-435 ◽  
Author(s):  
Maria S. Altieri ◽  
Catherine Tuppo ◽  
Dana A. Telem ◽  
Darragh Herlihy ◽  
Kathryn Cottell ◽  
...  

2019 ◽  
Vol 156 (6) ◽  
pp. S-927-S-928
Author(s):  
Ashley C. Gilmore ◽  
Mohammad A. Al-Haddad ◽  
Mark A. Gromski

2012 ◽  
Vol 125 (6) ◽  
pp. 603.e7-603.e11 ◽  
Author(s):  
William C. Haas ◽  
Justin B. Moore ◽  
Michael Kaplan ◽  
Suzanne Lazorick

2008 ◽  
Vol 27 (1, Suppl) ◽  
pp. S91-S98 ◽  
Author(s):  
Sherry L. Pagoto ◽  
Lyle Kantor ◽  
Jamie S. Bodenlos ◽  
Mitchell Gitkind ◽  
Yunsheng Ma

2011 ◽  
Vol 41 (10) ◽  
pp. 34
Author(s):  
M. ALEXANDER OTTO

Sign in / Sign up

Export Citation Format

Share Document